Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: ValuEngine, Inc.
Provider: Stock Traders Daily
Provider: ValuEngine, Inc.

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Sarah Cannon Research Institute And AstraZeneca PLC Announce Personalized Medicine Partnership and Enhanced Strategic Clinical Development Collaboration

Monday, 1 Jul 2013 06:00am EDT 

Sarah Cannon Research Institute (SCRI) and AstraZeneca (AZ) announced today a collaboration in the field of personalized medicine to support development of new AstraZeneca oncology compounds. Specifically, the parties will work together on molecular profiling to classify tissue based upon genetic profiles for the purpose of treating cancers and predicting response to therapy. 

Company Quote

53.0 +1.12%
20 Apr 2015